News & Announcements
-
Board Changes
/**/ RNS Number : 7342I Imaging Biometrics Limited 24 November 2025 Imaging Biometrics Limited (“IBAI” or the “Company”) Board Changes The Company announces that Dr Al Musella will step down from the Board of Directors with effect from 31 December 2025. Although Dr Musella will no longer serve on the IBAI
-
Fractional Tumor Burden Mapping Enhances GBM Trial
/**/ RNS Number : 4541H Imaging Biometrics Limited 13 November 2025 Imaging Biometrics Limited (“IB” or the “Company”) Imaging Biometrics’ Fractional Tumor Burden Mapping Enhances GBM Trial A glioblastoma (GBM) clinical trial led by Dr. Danielle Bazer, DO, neuro-oncologist and Lead for Neuro-Oncology at MD Anderson Cancer Center at Cooper University, is
-
IB Announces Completion of Phase 1 Trial of GaM
/**/ RNS Number : 9232G Imaging Biometrics Limited 10 November 2025 Imaging Biometrics, Ltd (the “Company”) Imaging Biometrics Announces Successful Completion of Phase 1 Trial of Gallium Maltolate in Recurrent Glioblastoma Imaging Biometrics, LLC, (“IB”), a leader in advanced quantitative imaging solutions, today announces the successful completion of its Phase 1 clinical
-
Further Re: Purchase of interest in Kirkstall Ltd
/**/ RNS Number : 5711D Imaging Biometrics Limited 16 October 2025 Imaging Biometrics Limited (“IBAI” or the “Company”) Further Re: Purchase of interest in Kirkstall Limited Imaging Biometrics Limited Limited (LSE: IBAI), provides an update following its announcement on 14 October 2025 regarding the purchase of the Company‘s interest in Kirkstall Limited (“Kirkstall”) from Truetide
-
Purchase of Kirkstall and CLN – Correction
/**/ RNS Number : 3286D Imaging Biometrics Limited 14 October 2025 Imaging Biometrics Limited (“IBAI” or the “Company”) Purchase of Kirkstall Limited and CLN with Truetide plc – Correction The following amendment has been made to the Purchase of Kirkstall Limited and CLN with Trueside plc announcement released on 14.10.25 at 7am.